A pair of leading subject matter experts discuss the current landscape of atopic dermatitis, including unmet needs, and the role of IL-13 inhibition in the management.
Panelists discuss how understanding the causes of iron deficiency in pregnancy, selecting appropriate supplementation strategies, and collaborating between OB/GYNs and hematologists are crucial for effective management and ensuring optimal care for pregnant women.
Panelists discuss how accurately diagnosing iron deficiency, selecting appropriate treatments like oral or IV iron, educating patients, and collaborating with specialists are essential for effective management and improving outcomes in hematology practice.
Panelists discuss how understanding the causes of iron deficiency anemia, selecting appropriate treatments like IV iron, and tailoring therapies to individual patient needs are critical for effective management, particularly in patients with gastrointestinal conditions.
Panelists discuss how bempedoic acid offers a promising alternative for patients who are statin-intolerant patients, demonstrating efficacy in reducing major cardiovascular events and low-density lipoproteinLDL cholesterol, while addressing its role in managing residual cardiovascular risk, particularly in high-risk populations.
Lauren Miller, MPAS, PA-C; Jayme M. Heim, MSN FNP-BC, and Kirk Gautier, PA-C, discuss recent advancements in plaque psoriasis treatment, focusing on novel oral systemic therapies like the TYK-2 inhibitor deucravacitinib and its clinical trial data, to inform therapeutic decisions for this systemic disease.
Nehad Soloman, MD, FACR; Andrew Sharobeem, DO, FACR, and Sunil Patel, MD, explore the nephrologist's vital role in gout diagnosis, treatment options for gout patients with chronic kidney disease, and strategies for managing refractory gout and its associated challenges.
Plaque psoriasis experts explore recent advancements in treatment options, patient experiences, and the potential of novel oral systemic therapies to reduce the burden of this prevalent chronic condition.
Key opinion leaders analyze EULAR 2024 updates on gout, chronic inflammation's systemic impact, and gout-chronic kidney disease (CKD) connections, while examining urate-lowering therapies for gout management, particularly in patients with CKD.
A panel of ophthalmologists discuss strategies for improving patient outcomes in retinal vein occlusion with anti-VEGF and other therapies.
Experts discuss strategies for making dry eye care an appealing practice option for optometry students and supporting their success in this specialized field.
Medical experts explore evidence-based strategies to decelerate the progression of psoriasis and psoriatic arthritis, aiming to optimize patient outcomes and enhance long-term disease management.
Experts discuss strategies for making dry eye care an appealing practice option for optometry students and supporting their success in this specialized field.
A panel of ophthalmologists discuss strategies for managing AMD and DME patients who exhibit suboptimal responses to their current anti-VEGF therapy.
Expert dermatologists have a comprehensive discussion on exciting developments in the treatment of plaque psoriasis, focusing on treatment approaches, patient monitoring strategies, and recent long term clinical trial data on oral agent deucravacitinib.
A panel of ophthalmologists discuss how retinal disease management has evolved in the past decade and continues to change with advancements in diagnostics and therapies.
Experts discuss strategies for making dry eye care an appealing practice option for optometry students and supporting their success in this specialized field.
Lauren Miller, MPAS, PA-C, leads an expert discussion surrounding exciting developments in the treatment landscape of plaque psoriasis.
Experts discuss treating dry eye with procedural therapies, focusing on common in-office and at-home treatments.
Experts discuss the management of dry eye in the presence of concurrent ocular conditions, as well as managing dry eye before undergoing cataract and refractive surgery.
Experts discuss the management of dry eye using conventional and new pharmacological treatments, as well as strategies for tailoring treatment approaches to individual patient characteristics.
Advanced practice providers in dermatology discuss exciting developments in the treatment landscape of plaque psoriasis. Listen to their insights into the often-challenging journey patients go on. The arrival of novel oral systemic treatment options offers opportunities to alleviate the burden of this chronic disease.
In this discussion, experts focus on emerging treatment options for gout and share tips for monitoring and managing gout in patients with comorbid conditions.
Expert rheumatologists discuss current treatment options for lupus nephritis and emerging therapies with newer mechanisms of action.
Dr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.
Expert rheumatologists discuss precision medicine in rheumatoid arthritis. In particular, they discuss available data and the value of various tools in guiding treatment selection in routine clinical practice.
In this episode of MEDcast, expert dermatologists delve into the practical aspects of using photodynamic therapy (PDT) for treatment of actinic keratosis. Specialists are sharing their protocols, advances in PDT delivery, tips for training clinical staff and communicating with patients.
Retina specialists evaluate the effectiveness of the two new therapies for neovascular AMD and DME by analyzing their respective clinical trial methodologies and outcomes.
Experts discuss the intricate relationship between diabetes, kidney disease, and cardiovascular function and explore the evolving landscape of therapies with cardiorenal benefits.
